NESCO Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: June 29, 2025, 11:11 am

Competitors of NESCO Ltd

All Competitor Stocks of NESCO Ltd

Quarterly Result

Last Updated: May 31, 2025, 8:18 am

Below is a detailed analysis of the quarterly data for NESCO Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 192.00 Cr.. The value appears to be declining and may need further review. It has decreased from 207.00 Cr. (Dec 2024) to 192.00 Cr., marking a decrease of 15.00 Cr..
• For Expenses, as of Mar 2025, the value is 85.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.00 Cr. (Dec 2024) to 85.00 Cr., marking an increase of 4.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 107.00 Cr.. The value appears to be declining and may need further review. It has decreased from 125.00 Cr. (Dec 2024) to 107.00 Cr., marking a decrease of 18.00 Cr..
• For OPM %, as of Mar 2025, the value is 56.00%. The value appears to be declining and may need further review. It has decreased from 61.00% (Dec 2024) to 56.00%, marking a decrease of 5.00%.
• For Other Income, as of Mar 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Dec 2024) to 20.00 Cr., marking a decrease of 11.00 Cr..
• For Interest, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Dec 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 13.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 112.00 Cr.. The value appears to be declining and may need further review. It has decreased from 142.00 Cr. (Dec 2024) to 112.00 Cr., marking a decrease of 30.00 Cr..
• For Tax %, as of Mar 2025, the value is 21.00%. The value appears to be improving (decreasing) as expected. It has decreased from 22.00% (Dec 2024) to 21.00%, marking a decrease of 1.00%.
• For Net Profit, as of Mar 2025, the value is 89.00 Cr.. The value appears to be declining and may need further review. It has decreased from 110.00 Cr. (Dec 2024) to 89.00 Cr., marking a decrease of 21.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 12.58. The value appears to be declining and may need further review. It has decreased from 15.60 (Dec 2024) to 12.58, marking a decrease of 3.02.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:39 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:38 am

Below is a detailed analysis of the balance sheet data for NESCO Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,615.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,282.00 Cr. (Mar 2024) to 2,615.00 Cr., marking an increase of 333.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 385.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 354.00 Cr. (Mar 2024) to 385.00 Cr., marking an increase of 31.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,016.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,650.00 Cr. (Mar 2024) to 3,016.00 Cr., marking an increase of 366.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 916.00 Cr.. The value appears strong and on an upward trend. It has increased from 757.00 Cr. (Mar 2024) to 916.00 Cr., marking an increase of 159.00 Cr..
• For CWIP, as of Mar 2025, the value is 753.00 Cr.. The value appears strong and on an upward trend. It has increased from 162.00 Cr. (Mar 2024) to 753.00 Cr., marking an increase of 591.00 Cr..
• For Investments, as of Mar 2025, the value is 1,136.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,494.00 Cr. (Mar 2024) to 1,136.00 Cr., marking a decrease of 358.00 Cr..
• For Other Assets, as of Mar 2025, the value is 211.00 Cr.. The value appears to be declining and may need further review. It has decreased from 237.00 Cr. (Mar 2024) to 211.00 Cr., marking a decrease of 26.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,016.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,650.00 Cr. (Mar 2024) to 3,016.00 Cr., marking an increase of 366.00 Cr..

Notably, the Reserves (2,615.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for NESCO Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 23, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
• For Diluted EPS (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
• For Cash EPS (Rs.), as of Mar 23, the value is 45.90. This value is within the healthy range. It has increased from 30.87 (Mar 22) to 45.90, marking an increase of 15.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 278.82. It has increased from 240.95 (Mar 22) to 278.82, marking an increase of 37.87.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 278.82. It has increased from 240.95 (Mar 22) to 278.82, marking an increase of 37.87.
• For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 77.49. It has increased from 47.88 (Mar 22) to 77.49, marking an increase of 29.61.
• For PBDIT / Share (Rs.), as of Mar 23, the value is 58.47. This value is within the healthy range. It has increased from 37.47 (Mar 22) to 58.47, marking an increase of 21.00.
• For PBIT / Share (Rs.), as of Mar 23, the value is 53.81. This value is within the healthy range. It has increased from 33.45 (Mar 22) to 53.81, marking an increase of 20.36.
• For PBT / Share (Rs.), as of Mar 23, the value is 52.08. This value is within the healthy range. It has increased from 32.14 (Mar 22) to 52.08, marking an increase of 19.94.
• For Net Profit / Share (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
• For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 41.25. This value is within the healthy range. It has increased from 26.85 (Mar 22) to 41.25, marking an increase of 14.40.
• For PBDIT Margin (%), as of Mar 23, the value is 75.45. This value is within the healthy range. It has decreased from 78.24 (Mar 22) to 75.45, marking a decrease of 2.79.
• For PBIT Margin (%), as of Mar 23, the value is 69.44. This value exceeds the healthy maximum of 20. It has decreased from 69.85 (Mar 22) to 69.44, marking a decrease of 0.41.
• For PBT Margin (%), as of Mar 23, the value is 67.21. This value is within the healthy range. It has increased from 67.11 (Mar 22) to 67.21, marking an increase of 0.10.
• For Net Profit Margin (%), as of Mar 23, the value is 53.22. This value exceeds the healthy maximum of 10. It has decreased from 56.06 (Mar 22) to 53.22, marking a decrease of 2.84.
• For NP After MI And SOA Margin (%), as of Mar 23, the value is 53.22. This value exceeds the healthy maximum of 20. It has decreased from 56.06 (Mar 22) to 53.22, marking a decrease of 2.84.
• For Return on Networth / Equity (%), as of Mar 23, the value is 14.79. This value is below the healthy minimum of 15. It has increased from 11.14 (Mar 22) to 14.79, marking an increase of 3.65.
• For Return on Capital Employeed (%), as of Mar 23, the value is 17.63. This value is within the healthy range. It has increased from 12.43 (Mar 22) to 17.63, marking an increase of 5.20.
• For Return On Assets (%), as of Mar 23, the value is 12.84. This value is within the healthy range. It has increased from 9.59 (Mar 22) to 12.84, marking an increase of 3.25.
• For Asset Turnover Ratio (%), as of Mar 23, the value is 0.25. It has increased from 0.17 (Mar 22) to 0.25, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 23, the value is 4.70. This value exceeds the healthy maximum of 3. It has increased from 3.73 (Mar 22) to 4.70, marking an increase of 0.97.
• For Quick Ratio (X), as of Mar 23, the value is 4.59. This value exceeds the healthy maximum of 2. It has increased from 3.63 (Mar 22) to 4.59, marking an increase of 0.96.
• For Inventory Turnover Ratio (X), as of Mar 23, the value is 3.89. This value is below the healthy minimum of 4. It has increased from 3.40 (Mar 22) to 3.89, marking an increase of 0.49.
• For Dividend Payout Ratio (NP) (%), as of Mar 23, the value is 7.27. This value is below the healthy minimum of 20. It has decreased from 11.17 (Mar 22) to 7.27, marking a decrease of 3.90.
• For Dividend Payout Ratio (CP) (%), as of Mar 23, the value is 6.53. This value is below the healthy minimum of 20. It has decreased from 9.71 (Mar 22) to 6.53, marking a decrease of 3.18.
• For Earning Retention Ratio (%), as of Mar 23, the value is 92.73. This value exceeds the healthy maximum of 70. It has increased from 88.83 (Mar 22) to 92.73, marking an increase of 3.90.
• For Cash Earning Retention Ratio (%), as of Mar 23, the value is 93.47. This value exceeds the healthy maximum of 70. It has increased from 90.29 (Mar 22) to 93.47, marking an increase of 3.18.
• For Interest Coverage Ratio (X), as of Mar 23, the value is 33.74. This value is within the healthy range. It has increased from 28.63 (Mar 22) to 33.74, marking an increase of 5.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 24.80. This value is within the healthy range. It has increased from 21.52 (Mar 22) to 24.80, marking an increase of 3.28.
• For Enterprise Value (Cr.), as of Mar 23, the value is 3,626.03. It has decreased from 3,885.86 (Mar 22) to 3,626.03, marking a decrease of 259.83.
• For EV / Net Operating Revenue (X), as of Mar 23, the value is 6.64. This value exceeds the healthy maximum of 3. It has decreased from 11.52 (Mar 22) to 6.64, marking a decrease of 4.88.
• For EV / EBITDA (X), as of Mar 23, the value is 8.80. This value is within the healthy range. It has decreased from 14.72 (Mar 22) to 8.80, marking a decrease of 5.92.
• For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 6.67. This value exceeds the healthy maximum of 3. It has decreased from 11.55 (Mar 22) to 6.67, marking a decrease of 4.88.
• For Retention Ratios (%), as of Mar 23, the value is 92.72. This value exceeds the healthy maximum of 70. It has increased from 88.82 (Mar 22) to 92.72, marking an increase of 3.90.
• For Price / BV (X), as of Mar 23, the value is 1.85. This value is within the healthy range. It has decreased from 2.29 (Mar 22) to 1.85, marking a decrease of 0.44.
• For Price / Net Operating Revenue (X), as of Mar 23, the value is 6.67. This value exceeds the healthy maximum of 3. It has decreased from 11.55 (Mar 22) to 6.67, marking a decrease of 4.88.
• For EarningsYield, as of Mar 23, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 22) to 0.07, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness